I agree and understand.
But keep in mind, there is value in the underlying Intellectual Property and Patents.
It then becomes a matter of identifying the potential application of that IP and Patent.
I think the real opportunity for GTG at the moment is to get momentum with their Multi-test product and tap into government subsidised funding, as preventative medicine will save governments lots of money. So GTG management need to build better relationships and/or employ people with those established relationships.
Hopefully EasyDNA will also give them some more global visibility and opportunity for increased sales.
- Forums
- ASX - By Stock
- GTG
- News: GTG Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent...
News: GTG Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent..., page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTG (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
0.001(2.50%) |
Mkt cap ! $5.962M |
Open | High | Low | Value | Volume |
4.2¢ | 4.2¢ | 4.0¢ | $509 | 12.72K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 171524 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 39777 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 171524 | 0.039 |
6 | 445749 | 0.038 |
6 | 91062 | 0.037 |
2 | 27082 | 0.036 |
1 | 3 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 43383 | 3 |
0.045 | 22522 | 1 |
0.046 | 40000 | 1 |
0.049 | 2414 | 1 |
0.050 | 25556 | 2 |
Last trade - 11.54am 11/10/2024 (20 minute delay) ? |
Featured News
GTG (ASX) Chart |